2009
DOI: 10.1021/jo9014497
|View full text |Cite
|
Sign up to set email alerts
|

Enantioselective Syntheses of α-Fmoc-Pbf-[2-13C]-l-arginine and Fmoc-[1,3-13C2]-l-proline and Incorporation into the Neurotensin Receptor 1 Ligand, NT8−13

Abstract: Enantioselective syntheses of selectively labeled, orthogonally protected [2-(13)C]-L-arginine and [1,3-(13)C(2)]-L-proline are described from the commercially available precursors [2-(13)C]bromoacetic acid and potassium [(13)C]cyanide. Interestingly the enhanced signal assigned to C-2 in the (13)C NMR spectrum of alpha-Fmoc-Pbf-[2-(13)C]-L-arginine was very broad at room temperature. The two Fmoc-labeled amino acids were used to prepare [2-(13)C]-Arg9 and [1,3-(13)C(2)]-Pro10 labeled ligand (NT(8-13)) by manu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 33 publications
0
5
0
Order By: Relevance
“…Modified literature protocols were used to synthesize [1′,2′,3′,4′,5′,6′-13 C 6 ]-2-(β-D-glucopyranosyl)-3-isoxazolin-5-one [1′,2′,3′,4′,5′,6′-13 C 6 ]-1, 37 [1′,2′,3′,4′,5′,6′- 13 18,40 and [1-13 C 15 N]-3-(hydroxyimino)propanoate (4). 39 The details of the synthetic protocols as well as the analytical data are presented in the ESI (S5-S16).…”
Section: Synthesesmentioning
confidence: 99%
See 1 more Smart Citation
“…Modified literature protocols were used to synthesize [1′,2′,3′,4′,5′,6′-13 C 6 ]-2-(β-D-glucopyranosyl)-3-isoxazolin-5-one [1′,2′,3′,4′,5′,6′-13 C 6 ]-1, 37 [1′,2′,3′,4′,5′,6′- 13 18,40 and [1-13 C 15 N]-3-(hydroxyimino)propanoate (4). 39 The details of the synthetic protocols as well as the analytical data are presented in the ESI (S5-S16).…”
Section: Synthesesmentioning
confidence: 99%
“…Modified literature protocols were used to synthesize [1′,2′,3′,4′,5′,6′- 13 38 2,2,2-trichloroethyl-3-nitropropanoate ( 6), 38 isoxazolin-5-(2H)-one (5), 39 [1-13 C 15 N]-3-(hydroxyamino)propanoate (3) 18,40 and [1-13 C 15 N]-3-(hydroxyimino)propanoate (4). 39 The details of the synthetic protocols as well as the analytical data are presented in the ESI (S5-S16).…”
Section: Synthesesmentioning
confidence: 99%
“…It requires solid-phase peptide synthesis or chemical synthesis. This approach has been used extensively to study amyloid peptides, membrane peptides and GPCR ligand conformation [46,64,[147][148][149][150][151]. Selective labelling, including forward and reverse labelling, refers to the biosynthetic incorporation of a single type or several types of labelled amino acid(s) with the rest unlabelled into the protein expression media.…”
Section: Expression Systems and Isotope Labelling Strategiesmentioning
confidence: 99%
“…Synthetic guanidines are also extremely versatile as catalysts, as components of ionic liquids, [110][111][112][113][114][115][116][117][118][119][120] in nucleotide mimetics, [121][122][123][124][125][126] in peptide mimetics, [127][128][129][130][131][132][133][134][135][136][137] as counter-ions in anion receptor chemistry, [138][139][140][141][142][143][144][145][146][147][148][149][150][151] as super-bases, [152][153][154] as molecular transporters, [155][156][157][158]…”
mentioning
confidence: 99%